Hopp til hovedinnhold
Home
language-selector-globe Norway | no
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Norway
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Om oss 
      • Novartis i Norge 
      • Produkter 
      • Det globale styret i Novartis 
      • Forskning og utvikling 
      • Samarbeid 
      • Kliniske studier 
      • Pengeoverføring til helsetjenesten 
      Kvinnelig forsker på lab Om oss
    • Pasienter og pårørende 
      • Vårt løfte til pasienter og pårørende 
      • Utprøvende behandling - noe for deg? 
      • Behandlingsområder 
      • Bivirkningsrapportering 
      Venner med en kopp varm te på fjelltur Pasienter og pårørende
    • Nyheter 
      • Nyheter 
      • Pressefoto 
      • Pressekontakt 
      A photo of people in a meeting hall Nyheter
    • Bærekraft 
      • Vi jobber målrettet med bærekraft 
      • Etiske retningslinjer 
      • Arbeid med menneskerettighetene 
      Bærekraft Bærekraft
    • Helsepersonell 
      • Ressursside for helsepersonell 
      • Produkter 
      • Bivirkningsrapportering 
      • Klinske studier 
      • Forskning og utvikling 
      Helsepersonell Helsepersonell
    • Jobbe i Novartis 
      • Ledige stillinger 
      • Jobbe i Novartis 
      • Trivsel på jobben 
      Forretningskvinne ved trappen på kontoret Jobbe i Novartis
    • Kontakt oss 
    Mennesker i laboratorie Hjem
  1. Home
  2. Ledige stillinger
  3. Ledige stillinger
  • Sort by Sort ascending
  • Stillingstittel
  • Sted
  • Land
  • Avdeling
  • Avdeling
  • Functional Area
  • Dato publisert Sorter stigende
Stillingstittel Sted Land Avdeling Avdeling Functional Area Dato publisert Sorter stigende
R2R Lead Israel Israel Israel Finance CTS Audit & Finance sep 16, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance sep 13, 2024
Record to Report Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance sep 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES Mexico Operations CTS Audit & Finance sep 10, 2024
Record to Report Sr Specialist US INSURGENTES Mexico Operations CTS Audit & Finance sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance sep 10, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit & Finance sep 06, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance sep 05, 2024
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance sep 05, 2024
BPA & R2R Analyst Amsterdam Netherlands Finance Innovative Medicines Audit & Finance sep 04, 2024
TCM Senior Cash Management Specialist INSURGENTES Mexico Operations CTS Audit & Finance aug 30, 2024
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Audit & Finance aug 29, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations CTS Audit & Finance aug 22, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance aug 22, 2024
ERP Assurance Senior Consultant-2 INSURGENTES Mexico Finance CTS Audit & Finance aug 20, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance aug 19, 2024
LDC Adopt Process Lead - Taxes INSURGENTES Mexico Operations CTS Audit & Finance aug 19, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit & Finance aug 12, 2024
Order to Cash Radioligand Therapy Sr. Specialist INSURGENTES Mexico Finance CTS Audit & Finance aug 06, 2024
BPA Planning Process, RLT Baarle Nassau Netherlands Finance Innovative Medicines Audit & Finance aug 05, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance jul 28, 2024
Procure to Pay Senior Specialist MR11 INSURGENTES Mexico Finance CTS Audit & Finance jul 23, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance jul 22, 2024
SAP Security Manager Prague Czech Republic Operations CTS Audit & Finance jul 22, 2024
ERP Assurance Senior Consultant Selangor Malaysia Operations CTS Audit & Finance jul 17, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit & Finance jul 17, 2024
P2P & T&E Specialist (Arabic Speaker) Selangor Malaysia Finance CTS Audit & Finance jul 05, 2024
Senior Financial Reporting and Accounting Specialist Prague Czech Republic Finance CTS Audit & Finance jul 03, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance jun 26, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit & Finance jun 20, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance jun 20, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance jun 13, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance jun 12, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance jun 05, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance mai 31, 2024

Sider

  • ‹ Forrige side
  • 1
  • 2

Novartis Norge

Bli kjent med Novartis
  • Om oss
  • Kontakt oss
  • Jobbe i Novartis
  • Informasjon til pasienter og pårørende
Nyheter og medieressurser
  • Nyheter
  • Pressefoto
  • Pressekontakt
Våre behandlinger
  • Våre legemidler
  • Behandlingsområder
  • Forskning og utvikling
  • Informasjon til helsepersonell
Novartis' andre nettsider
  • Novartis Globalt
  • MedHub Norge
Bunntekst-bunn
© 2024 Novartis Norge
  • Personvern og GDPR
  • Brukervilkår for denne nettsiden
  • Informasjon om informasjonskapsler
  • Oversikt over denne nettsiden
  • Tilgjengelig
Novartis' andre nettsider
Denne nettsiden er beregnet på norske besøkende